-
Mashup Score: 1Factors associated with the development of severe asthma - 4 day(s) ago
Severe asthma presents a major challenge to health care and negatively affects the quality of life of patients. Understanding the factors predicting the development of severe asthma is limited.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0The use of grocery-sourced real-food solutions in sublingual immunotherapy for food allergies - 6 day(s) ago
Sublingual immunotherapy (SLIT) is a safe, effective therapy for the treatment of food allergy. Studies demonstrating SLIT efficacy have primarily used pharmaceutical glycerinated food extracts for the administration of food allergens, which may limit accessibility due to extract cost and availability.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0ACAAI Annals Fellow-in-Training Award Program - ACAAI Member - 9 day(s) ago
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Source: college.acaai.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0Can ChatGPT provide parent education for oral immunotherapy? - 13 day(s) ago
Oral Immunotherapy (OIT) has exhibited great potential in the treatment of food allergy. However, there is no global consensus on best practices of OIT. Parents of allergic children often struggle with concerns regarding OIT methodology, safety, and lack of accessible educational resources. ChatGPT is a generative artificial intelligence chatbot from OpenAI recognized for its ability to formulate human-like conversations. Although applications of artificial intelligence in medical settings continue to be explored, the effectiveness of ChatGPT as an educational resource remains unknown for OIT.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 4Management of indolent mastocytosis and mast cell activation syndrome: A clinical yardstick - 18 day(s) ago
Knowledge and understanding of mast cell biology and mast cell disorders has increased in the past several years, with new classifications of diseases for both clonal and non-clonal forms. Along with these classifications has come differing treatment paradigms, including novel therapies now approved for various forms of clonal mast cell disorders. Unfortunately, there is some lack of guidance on how best to utilize these therapies. This yardstick aims to provide the clinician with a review of available therapies to treat mast cell activation syndrome and indolent systemic mastocytosis and an evidence-based expert opinion approach regarding how best to utilize these therapies.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0ACAAI Annals Fellow-in-Training Award Program - ACAAI Member - 20 day(s) ago
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
Source: college.acaai.orgCategories: General Medicine NewsTweet
-
Mashup Score: 2Weighing real-world studies when choosing a biologic for asthma - 25 day(s) ago
The past decade has seen a proliferation in biologic therapies for moderate to severe asthma, with 5 therapies gaining US Food and Drug Administration (FDA) approval in 6 years. Though this treatment expansion adds new opportunities for patients with previously untargeted phenotypes or previous biologic failure, it has also increased the complexity of selecting the most appropriate biologic for each individual. The choice of a biologic may be on the basis of administration frequency, safety, and comorbidity treatment but is often heavily influenced by phenotype- and biomarker-directed clinical efficacy.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 4Sleep disruption in chronic rhinosinusitis improves using exhalation-delivery nasal steroid therapy - 27 day(s) ago
Chronic rhinosinusitis is a common inflammatory condition that often leads to significant sleep disturbances, negatively affecting quality of life. Although intranasal steroids are a standard treatment, their effect on sleep disturbances in chronic rhinosinusitis has not been extensively studied.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0How we treat mast cell activation syndrome - 1 month(s) ago
Mast cell activation syndrome (MCAS) is a heterogeneous, uncommon entity presenting with acute, recurrent episodes of severe systemic symptoms, which may have clonal or nonclonal etiologies. These symptoms are associated with the excessive release of mast cell (MC) mediators and often present as anaphylaxis.1-3 Recently, MCAS has gained increased recognition from both the general public and medical providers; however, there remains considerable confusion in its diagnosis due to many gaps in knowledge in this field.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma - 1 month(s) ago
Patients with chronic rhinosinusitis with nasal polyps comorbid with asthma often experience poor outcomes after endoscopic sinus surgery.
Source: www.annallergy.orgCategories: General Medicine NewsTweet
Although patients with severe asthma constitute a fraction of the total asthma patients, severe asthma treatment contributes a high proportion to the total economic burden. Understanding patient factors underlying severe asthma is thus a key priority. https://t.co/5XyJPHB5cJ